LCLin Cui

Lin Cui

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lin Cui has a total of 38 co-authors. Here are the top co-authors by number of shared publications:

  • Vicky Elizabeth MacRae

    The Roslin Institute and R(D)SVS, University of Edinburgh, Easter Bush, Midlothian EH25 9RH, UK

    5 shared publications
  • Colin Farquharson

    The Roslin Institute and Royal (Dick) School of Veterinary Studies University of Edinburgh Midlothian UK

    4 shared publications
  • Brendan M. Corcoran

    The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Midlothian EH25 9RG, UK

    2 shared publications
  • Dongxing Zhu

    Guangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital, School of Basic Medical Sciences, Guangzhou Medical University, China (Y.X., H.Z., G.Z., Liang Yuan, K.L., D.Z.).

    2 shared publications
  • Marc Richard Dweck

    University of Edinburgh

    2 shared publications
  • Nabil A. Rashdan

    The Roslin Institute, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK

    2 shared publications

Latest Publications

  • Open Access

    Osteocalcin Regulates Arterial Calcification Via Altered Wnt Signaling and Glucose Metabolism

    by Nabil A Rashdan, Alisia M Sim, Lin Cui, Kanchan Phadwal, Fiona L Roberts, Roderick Carter, Derya D Ozdemir, Peter Hohenstein, John Hung, Jakub Kaczynski, et al.

    Arterial calcification is an important hallmark of cardiovascular disease and shares many similarities with skeletal mineralisation. The bone‐specific protein osteocalcin (OCN) is an established marker of vascular smooth muscle cell (VSMC) osteochondrogenic trans‐differentiation and a known regulator of glucose metabolism. However, the role of OCN in controlling arterial calcification is unclear. We hypothesised that OCN regulates calcification in VSMCs and sought to identify the underpinning signalling pathways. Immunohistochemistry revealed OCN co‐localisation with VSMC calcification in human calcified carotid artery plaques. Additionally, 3 mM phosphate treatment stimulated OCN mRNA expression in cultured VSMCs (1.72 fold; p < 0.001). Phosphate‐induced calcification was blunted in VSMCs derived from OCN null mice (Ocn−/−) compared to cells derived from Wild‐Type (WT) mice (0.37 fold, p < 0.001). Ocn−/− VSMCs showed reduced mRNA expression of the osteogenic marker Runx2 (0.51 fold, p < 0.01) and the sodium‐dependent phosphate transporter, PiT1 (0.70 fold, p < 0.001), with an increase in the calcification inhibitor Mgp (1.42 fold, p < 0.05) compared to WT. Ocn−/− VSMCs also showed reduced mRNA expression of Axin2 (0.13 fold; p < 0.001) and Cyclin D (0.71 fold; p < 0.01), markers of Wnt signalling. CHIR99021 (GSK3β inhibitor) treatment increased calcium deposition in WT and Ocn−/− VSMCs (1 μM; p < 0.001). Ocn−/− VSMCs however calcified less than WT cells (1 μM; 0.27 fold; p < 0.001). Ocn−/− VSMCs showed reduced mRNA expression of Glut1 (0.78 fold p < 0.001), Hex1 (0.77 fold p < 0.01) and Pdk4 (0.47 fold p < 0.001). This was accompanied by reduced glucose uptake (0.38 fold, p < 0.05). Subsequent mitochondrial function assessment revealed increased ATP‐linked respiration (1.29 fold, p < 0.05), spare respiratory capacity (1.59 fold, p < 0.01) and maximal respiration (1.52 fold, p < 0.001) in Ocn−/− versus WT VSMCs. Together these data suggest that OCN plays a crucial role in arterial calcification mediated by Wnt/β‐catenin signalling through reduced maximal respiration. Mitochondrial dynamics may therefore represent a novel therapeutic target for clinical intervention.


  • Open Access

    A novel fluorescein-bisphosphonate based diagnostic tool for the detection of hydroxyapatite in both cell and tissue models

    by Alisia M. Sim, Nabil A. Rashdan, Lin Cui, Alastair J. Moss, Fabio Nudelman, Marc R. Dweck, Vicky E. MacRae, Alison N. Hulme

    A rapid and efficient method for the detection of hydroxyapatite (HAP) has been developed which shows superiority to existing well-established methods. This fluorescein-bisphosphonate probe is highly selective for HAP over other calcium minerals and is capable of detecting lower levels of calcification in cellular models than either hydrochloric acid-based calcium leaching assays or the Alizarin S stain. The probe has been shown to be effective in both in vitro vascular calcification models and in vitro bone calcification models. Moreover we have demonstrated binding of this probe to vascular calcification in rat aorta and to areas of microcalcification, in human vascular tissue, beyond the resolution of computed tomography in human atherosclerotic plaques. Fluorescein-BP is therefore a highly sensitive and specific imaging probe for the detection of vascular calcification, with the potential to improve not only ex vivo assessments of HAP deposition but also the detection of vascular microcalcification in humans.


  • Open Access

    Exploiting novel valve interstitial cell lines to study calcific aortic valve disease

    by Hiu‑Gwen Tsang, Lin Cui, Colin Farquharson, Brendan M. Corcoran, Kim M. Summers, Vicky E. Macrae

    Calcific aortic valve disease (CAVD) involves progressive valve leaflet thickening and severe calcification, impairing leaflet motion. The in vitro calcification of primary rat, human, porcine and bovine aortic valve interstitial cells (VICs) is commonly employed to investigate CAVD mechanisms. However, to date, no published studies have utilised cell lines to investigate this process. The present study has therefore generated and evaluated the calcification potential of immortalized cell lines derived from sheep and rat VICs. Immortalised sheep (SAVIC) and rat (RAVIC) cell lines were produced by transduction with a recombinant lentivirus encoding the Simian virus (SV40) large and small T antigens (sheep), or large T antigen only (rat), which expressed markers of VICs (vimentin and α‑smooth muscle actin). Calcification was induced in the presence of calcium (Ca; 2.7 mM) in SAVICs (1.9 fold; P<0.001) and RAVICs (4.6 fold; P<0.01). Furthermore, a synergistic effect of calcium and phosphate was observed (2.7 mM Ca/2.0 mM Pi) on VIC calcification in the two cell lines (P<0.001). Analysis of SAVICs revealed significant increases in the mRNA expression of two key genes associated with vascular calcification in cells cultured under calcifying conditions, runt related transcription factor‑2 (RUNX2;1.3 fold; P<0.05 in 4.5 mM Ca) and sodium‑dependent phosphate transporter‑1 (PiT1; 1.2 fold; P<0.05 in 5.4 mM Ca). A concomitant decrease in the expression of the calcification inhibitor matrix Gla protein (MGP) was noted at 3.6 mM Ca (1.3 fold; P<0.01). Assessment of RAVICs revealed alterations in Runx2, Pit1 and Mgp mRNA expression levels (P<0.01). Furthermore, a significant reduction in calcification was observed in SAVICs following treatment with established calcification inhibitors, pyrophosphate (1.8 fold; P<0.01) and etidronate (3.2 fold; P<0.01). Overall, the present study demonstrated that the use of immortalised sheep and rat VIC cell lines is a convenient and cost effective system to investigate CAVD in vitro, and will make a useful contribution to increasing current understanding of the pathophysiological process.


  • Open Access

    Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification

    by Cui Lin, Dongxing Zhu, Greg Markby, Brendan M. Corcoran, Colin Farquharson, Vicky E. Macrae

    Calcific aortic valve disease (CAVD) is characterized by the progressive thickening of the aortic valve leaflets. It is a condition frequently found in the elderly and end-stage renal disease (ESRD) patients, who commonly suffer from hyperphosphatemia and hypercalcemia. At present, there are no medication therapies that can stop its progression. The mechanisms that underlie this pathological process remain unclear. The aortic valve leaflet is composed of a thin layer of valve endothelial cells (VECs) on the outer surfaces of the aortic cusps, with valve interstitial cells (VICs) sandwiched between the VECs. The use of a rat model enables the in vitro study of ectopic calcification based on the in vivo physiopathological serum phosphate (Pi) and calcium (Ca) levels of patients who suffer from hyperphosphatemia and hypercalcemia. The described protocol details the isolation of a pure rat VIC population as shown by the expression of VIC markers: alpha-smooth muscle actin (α-SMA) vimentin and tissue growth factor beta (TGFβ) 1 and 2, and the absence of cluster of differentiation (CD) 31, a VEC marker. By expanding these VICs, biochemical, genetic, and imaging studies can be performed to study and unravel the key mediators underpinning CAVD.


  • Open Access

    End stage renal disease‐induced hypercalcemia may promote aortic valve calcification via Annexin VI enrichment of valve interstitial cell derived‐matrix vesicles

    by Lin Cui, Nabil A. Rashdan, Dongxing Zhu, Elspeth M. Milne, Paul Ajuh, Gillian Milne, Miep H. Helfrich, Kelvin Lim, Sai Prasad, Daniel A. Lerman, et al.

    Patients with end‐stage renal disease (ESRD) have elevated circulating calcium (Ca) and phosphate (Pi), and exhibit accelerated progression of calcific aortic valve disease (CAVD). We hypothesized that matrix vesicles (MVs) initiate the calcification process in CAVD. Ca induced rat valve interstitial cells (VICs) calcification at 4.5 mM (16.4‐fold; p < 0.05) whereas Pi treatment alone had no effect. Ca (2.7 mM) and Pi (2.5 mM) synergistically induced calcium deposition (10.8‐fold; p < 0.001) in VICs. Ca treatment increased the mRNA of the osteogenic markers Msx2, Runx2, and Alpl (p < 0.01). MVs were harvested by ultracentrifugation from VICs cultured with control or calcification media (containing 2.7 mM Ca and 2.5 mM Pi) for 16 hr. Proteomics analysis revealed the marked enrichment of exosomal proteins, including CD9, CD63, LAMP‐1, and LAMP‐2 and a concomitant up‐regulation of the Annexin family of calcium‐binding proteins. Of particular note Annexin VI was shown to be enriched in calcifying VIC‐derived MVs (51.9‐fold; p < 0.05). Through bioinformatic analysis using Ingenuity Pathway Analysis (IPA), the up‐regulation of canonical signaling pathways relevant to cardiovascular function were identified in calcifying VIC‐derived MVs, including aldosterone, Rho kinase, and metal binding. Further studies using human calcified valve tissue revealed the co‐localization of Annexin VI with areas of MVs in the extracellular matrix by transmission electron microscopy (TEM). Together these findings highlight a critical role for VIC‐derived MVs in CAVD. Furthermore, we identify calcium as a key driver of aortic valve calcification, which may directly underpin the increased susceptibility of ESRD patients to accelerated development of CAVD.


  • Open Access

    Characterisation of matrix vesicles in skeletal and soft tissue mineralisation

    by L. Cui, D.A. Houston, C. Farquharson, V.E. MacRae